July 6, 2020 / 2:05 AM / a month ago

BRIEF-Biotron Presenting New Data On Lead Hiv-1 Drug, BIT225

July 6 (Reuters) - Biotron Ltd:

* ADVISE THAT COMPANY IS PRESENTING NEW DATA ON ITS LEAD HIV-1 DRUG, BIT225

* DATA INDICATE THAT VIA ITS INHIBITION OF HIV-1 VIRAL PROTEIN VPU, BIT225 ENHANCES IMMUNE RESPONSE TO HIV Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below